Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 29, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 12, 2013

Alphavirus-based expression vectors: strategies and applications

I Frolov1, T A Hoffman, B M Prágai

  • 1Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110-1093, USA.

Proceedings of the National Academy of Sciences of the United States of America
|October 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cells.

Stem cell reports·2023
Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021
Same author

Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2.

bioRxiv : the preprint server for biology·2021
Same author

Molecular Virology of Chikungunya Virus.

Current topics in microbiology and immunology·2019
Same author

Diabetes mellitus, blood glucose and the risk of heart failure: A systematic review and meta-analysis of prospective studies.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Diabetes mellitus and the risk of sudden cardiac death: A systematic review and meta-analysis of prospective studies.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018

This review examines how scientists modify alphaviruses to create tools that deliver and express genes in various cell types. By engineering the virus's replication machinery, researchers can produce high levels of proteins or RNAs. While these viruses are typically harmful to host cells, specific genetic changes allow them to persist without killing the cell, enabling long-term gene expression. These tools are valuable for laboratory research, vaccine development, and potential gene therapy applications.

Area of Science:

  • Molecular virology and Alphavirus-based expression vectors research
  • Genetic engineering and biotechnology

Background:

The mechanisms governing efficient gene delivery remain a significant challenge in molecular biology. Prior research has shown that specific viral platforms can facilitate robust cytoplasmic protein production. However, the inherent toxicity of these platforms to vertebrate hosts limits their utility. That uncertainty drove the development of modified viral systems designed to balance expression levels with cellular viability. It was already known that recombinant RNA replicons could be initiated via diverse transfection methods. Yet, achieving sustained, non-lethal expression in mammalian systems has historically proven difficult. This gap motivated the exploration of adaptive mutations that alter viral replication kinetics. No prior work had resolved how to optimize these vectors for both transient and long-term therapeutic applications.

Purpose Of The Study:

The aim of this review is to describe the strategies used to engineer viral platforms for efficient gene expression. Researchers seek to address the limitations of traditional vectors that are often toxic to host cells. By modifying the replication machinery, scientists strive to achieve high-level expression of heterologous RNAs and proteins. The study explores how adaptive mutations can be utilized to create noncytopathic viral variants. This motivation stems from the need for tools that support both transient and long-term gene expression in mammalian cells. The authors examine the development of packaging systems for producing infectious viral particles. They also investigate the potential of these tools for applications in genetic vaccination and gene therapy. This work provides a comprehensive overview of how recombinant DNA technology has transformed these viruses into versatile molecular tools.

Keywords:
viral vectorsgene deliverymolecular biologyprotein expression

Frequently Asked Questions

The researchers propose that adaptive mutations allow these viral vectors to replicate without destroying the host cell. This contrasts with wild-type viruses, which are typically cytocidal to vertebrate cells, by enabling persistent, non-lethal gene expression.

The authors describe packaging systems as the primary tool for generating high titers of infectious viral particles. These systems are necessary to deliver the engineered RNA replicons into target cells efficiently.

The researchers state that DNA or RNA transfection is necessary to initiate the amplification of replication-competent viral RNAs. This step is required to start the intracellular replication cycle of the engineered replicon.

The authors explain that recombinant RNA replicons serve as the genetic material for expression. These molecules are engineered to hijack the host's cytoplasmic machinery for high-level protein synthesis.

More Related Videos

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Related Experiment Videos

Last Updated: Jun 29, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 12, 2013

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
06:41

Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors

Published on: October 20, 2023

Main Methods:

The review approach synthesizes data from studies utilizing recombinant DNA technology to modify viral replication machinery. Investigators examine how RNA or DNA transfection initiates the amplification of viral replicons. The authors evaluate various packaging systems developed to produce high titers of infectious particles. They analyze the mapping of adaptive mutations that allow for noncytopathic replication in mammalian cells. The study assesses the selection of these variants from persistently infected cultures or through dominant selectable markers. Researchers compare the performance of these new vectors against traditional platforms designed for short-term expression. The analysis focuses on the transition from high-level, transient expression to moderate, long-term protein production. Finally, the authors summarize the diverse applications of these tools in basic research and therapeutic development.

Main Results:

Key findings from the literature demonstrate that engineered viral replicons facilitate efficient cytoplasmic gene expression in both insect and vertebrate cells. The authors report that high-level protein production is achievable through the modification of viral replication machinery. They highlight that variants with adaptive mutations successfully enable noncytopathic replication in mammalian systems. These specific mutations were identified through selection in persistently infected cultures or by using dominant selectable markers. The literature indicates that these new vectors allow for long-term expression at moderate levels. This capability complements existing tools that were previously restricted to short-term, high-intensity protein production. Furthermore, the findings suggest that these systems are suitable for a growing number of basic research applications. The review notes that these recombinant replicons may also support advancements in genetic vaccination and transient gene therapy.

Conclusions:

The authors synthesize evidence regarding the evolution of viral vectors for genetic engineering. They highlight how adaptive mutations successfully mitigate the typical cytocidal effects observed in vertebrate hosts. These modified systems provide a versatile toolkit for both short-term high-level and long-term moderate-level gene expression. The review implies that these platforms are increasingly relevant for basic laboratory investigations. Furthermore, the authors suggest that these replicons hold promise for future genetic vaccination strategies. The synthesis indicates that transient gene therapy may also benefit from these engineered viral particles. Researchers emphasize that the choice of vector depends on the specific requirements for expression duration and intensity. Ultimately, the integration of these technologies expands the current capabilities for manipulating gene expression in diverse biological systems.

The researchers measure the success of these vectors by their ability to achieve moderate levels of long-term expression. This is compared to earlier versions that were limited to short-term, high-intensity protein production.

The authors propose that these modified replicons could facilitate genetic vaccination. They suggest this application is a potential future direction for transient gene therapy.